research.bayer.com

Bayer News & Stories | Bayer Global

Go to research.bayer.com

Research Bayer. Get inside glimpses of Bayer.

Read Research.bayer.com news digest here: view the latest Research Bayer articles and content updates right away or get to their most visited pages. Research.bayer.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that Research Bayer content is notably popular in India. We haven’t detected security issues or inappropriate content on Research.bayer.com and thus you can safely use it. Research.bayer.com is hosted with Amazon.com, Inc. (United States) and its basic language is English.

  • Content verdict: Safe
  • Website availability: Live
  • English language flagLanguage: English
  • Last check:

  • N/A

    Visitors daily

  • N/A

    Pageviews daily

  • 6

    Google PR

  • N/A

    Alexa rank

Research.bayer.com news digest

  • 11 months

    OCEANIC-AF study stopped early due to lack of efficacy

    Berlin, November 19, 2023 – OCEANIC-AF, a phase III study investigating asundexian compared to apixaban (a direct oral anticoagulant) in patients with atrial fibrillation at risk for stroke is being stopped early. This decision is based on the recommendation...

  • 1 year

    Third quarter below prior year as expected – Group outlook confirmed

    Leverkusen, November 8, 2023 – Bayer has confirmed its Group outlook for 2023 after posting third-quarter figures that were down against the previous year. “The results came in largely as we expected, knowing that Q3 is never our strongest quarter. The...

  • 1 year

    Bayer introduces agricultural system for direct-seeded rice with potential to re...

    Manila, Philippines, October 16, 2023 – On UN World Food Day, Bayer announced the introduction of its direct-seeded rice (DSR) system at the 6th International Rice Congress in Manila. Moving from transplanted puddled rice cultivation to direct-seeded...

  • 1 year

    Bayer to partner with Twist Bioscience to accelerate drug discovery

    Berlin, October 5, 2023 – Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.
    The company’s “Library of Libraries”, a collection of synthetic antibody libraries that harness innovative structural and developability features to cover a wide range of antibody drug targets, is tailored to address specific challenges in antibody discovery...

Domain history

Web host: Amazon.com, Inc.
Registrar: CSC Corporate Domains, Inc.
Registrant: Domain Administrator (Bayer AG)
Updated: January 22, 2023
Expires: January 26, 2025
Created: January 25, 1996

Whois record

Safety scores

Trustworthiness

Good

Child safety

N/A

Newly added profiles

More projects to check

Sites on this web host